Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study.
Ana-Lucia MayénMirna SabraElom K AglagoGabriel PerlemuterCosmin VoicanInes RamosCharlotte DebrasJessica BlancoVivian ViallonPietro FerrariAnja OlsenAnne TjønnelandFie LangmannChristina C DahmJoseph RothwellNasser LaoualiChloé MarquesMatthias B SchulzeVerena KatzkeRudolf KaaksDomenico PalliAlessandra MacciottaSalvatore PanicoRosario TuminoClaudia AgnoliMarta FarràsEsther Molina-MontesPilar AmianoMaría-Dolores ChirlaqueJesús CastillaMårten WernerStina BodénAlicia K HeathKostas TsilidisDagfinn AuneElisabete WeiderpassHeinz FreislingMarc J GunterMazda JenabPublished in: BMC medicine (2024)
Our findings based on a prospective cohort suggest that individuals with hepatic steatosis or metabolic dysfunction have a higher overall and cause-specific mortality risk.